Soitec Reports Fourth Quarter Revenue and Full-Year Results of Fiscal Year 2024
GlobeNewswire
*SOITEC REPORTS FOURTH QUARTER REVENUE AND*
*FULL-YEAR RESULTS OF FISCAL YEAR..
*SOITEC REPORTS FOURTH QUARTER REVENUE AND*
*FULL-YEAR RESULTS OF FISCAL YEAR..
· Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and..
· SIMLANDI is the first interchangeable high-concentration, citrate-free biosimilar to Humira^®REYKJAVIK, Iceland and PARSIPPANY,..